Showing results (281-290 of 542) with videos related to

Sort By:
Pageof 55
JCO Clinical Cancer Informatics|August 7, 2020
Natural Language Processing to Ascertain Cancer Outcomes From Medical Oncologist NotesKenneth L Kehl, Wenxin Xu, Eva Lepisto, et al.
Journal of Oncology Practice|February 13, 2018
Financial Distress, Use of Cost-Coping Strategies, and Adherence to Prescription Medication Among Patients With CancerLeah L Zullig, Jeffrey M Peppercorn, Deborah Schrag, et al.
Annals of Surgical Oncology|August 15, 2013
Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivorsHeather B Neuman, Jennifer M Weiss, Deborah Schrag, et al.
BMC Bioinformatics|September 1, 2023
Empirical evaluation of language modeling to ascertain cancer outcomes from clinical text reportsHaitham A Elmarakeby, Pavel S Trukhanov, Vidal M Arroyo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 19, 2019
Cost-Effectiveness of Web-Based Patient-Reported Outcome Surveillance in Patients With Lung CancerThibaut Lizée, Ethan Basch, Pierre Trémolières, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 11, 2009
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force reportStephen Joel Coons, Chad J Gwaltney, Ron D Hays, et al.
Journal of the National Cancer Institute|February 2, 2006
Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resectionDeborah Schrag, Craig Earle, Feng Xu, et al.
Medical Care|June 19, 2009
Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?K Robin Yabroff, Joan L Warren, Jessica Banthin, et al.
The Oncologist|February 16, 2012
Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancerThomas Delate, Daniel M Witt, Debra Ritzwoller, et al.
Pageof 55